Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Neurovirol. 2017 Jan 20;23(3):404–421. doi: 10.1007/s13365-016-0510-z

Figure 1.

Figure 1

Neurocognitive impairment differences across HIV serostatus groups using DSM-5, Frascati, and Gisslén neurocognitive criteria. Odds ratios (OR) reflect the increased likelihood for neurocognitive impairment given HIV+ serostatus.